Campbell-Sills, Laura
Sun, Xiaoying
Papini, Santiago
Choi, Karmel W.
He, Feng
Kessler, Ronald C. http://orcid.org/0000-0003-4831-2305
Ursano, Robert J. http://orcid.org/0000-0002-1861-9173
Jain, Sonia
Stein, Murray B. http://orcid.org/0000-0001-9564-2871
Funding for this research was provided by:
The University of California President’s Postdoctoral Fellowship Program
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K08MH127413, U01MH087981)
NARSAD Brain and Behavior Foundation Young Investigator Award
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Defense (HU00011520004, HU0001202003)
Article History
Received: 30 March 2023
Accepted: 24 April 2023
First Online: 19 May 2023
Competing interests
: In the past 3 years, Dr. Kessler was a consultant for Cambridge Health Alliance, Canandaigua VA Medical Center, Holmusk, Partners Healthcare, Inc., RallyPoint Networks, Inc., and Sage Therapeutics. He has stock options in Cerebral Inc., Mirah, PYM, and Roga Sciences. In the past 3 years, Dr. Stein has received consulting income from Acadia Pharmaceuticals, Aptinyx, atai Life Sciences, BigHealth, Bionomics, BioXcel Therapeutics, Boehringer Ingelheim, Clexio, Eisai, EmpowerPharm, Engrail Therapeutics, Janssen, Jazz Pharmaceuticals, NeuroTrauma Sciences, PureTech Health, Sumitomo Pharma, and Roche/Genentech. Dr. Stein has stock options in Oxeia Biopharmaceuticals and EpiVario. He has been paid for his editorial work on <i>Depression and Anxiety</i> (Editor-in-Chief), <i>Biological Psychiatry</i> (Deputy Editor), and <i>UpToDate</i> (Co-Editor-in-Chief for Psychiatry). He has also received research support from NIH, Department of Veterans Affairs, and the Department of Defense. He is on the scientific advisory board for the Brain and Behavior Research Foundation and the Anxiety and Depression Association of America. The other authors have no known conflicts of interest to declare.